Bridgefront Capital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bridgefront Capital’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,114	Closed	-$459K	–	1014
2021 Q1	$459K	Buy	+2,114	New	+$397K	0.14%	263

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Bridgefront Capital's GWPH Position: Q2 2021 in Review

Bridgefront Capital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 2,114 shares — an estimated $459K sold.

Bridgefront Capital first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $459K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Bridgefront Capital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Bridgefront Capital sold 2,114 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $459K.
Bridgefront Capital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Bridgefront Capital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $459K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Bridgefront Capital's 13F filing for Q2 2021, filed 12 Aug 2021.